Clinical Trial Update: Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and immunogenicity of GlaxoSmithKline meningococcal group B vaccine given with MenACWY conjugate vaccine in healthy infants; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• MenACWY Conjugate Vaccine (GSK) (MenACWY conjugate vaccine)
• Meningococcal group B vaccine (GSK) (meningococcal group B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 3 | Status: COMPLETED | Results posted: 2018-08-22